Sign in

CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880378336
Phone
(646) 677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
  1. 8-K Event Material agreement
  2. 424B5 Offering Prospectus
  3. 8-K Event Auditor change
  4. 10-Q Report Quarterly Report
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy CEO bought 10,000 shares at $0.79 ($7,900)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Principal Financial Officer bought 12,000 shares at $0.50 ($6,000)
  14. 10-Q Report Quarterly Report
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change
  17. 4 Open-market buy Chairman & CEO bought 5,000 shares at $0.38 ($1,900)
  18. 4 Other acquisition Chief Medical Officer acquired 14,000 shares (other)
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 10-K Report Annual Report

Page 11 of 26 · 511 filings